BTIG Downgrades Biogen (BIIB) to Neutral
Tweet Send to a Friend
BTIG analyst Thomas Shrader downgraded Biogen (NASDAQ: BIIB) from Buy to Neutral.The analyst comments "Earlier this morning, Biogen announced the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE